Cyanotech Corporation (CYAN)
- Previous Close
0.6900 - Open
0.7000 - Bid 0.6900 x 900
- Ask 0.7700 x 1200
- Day's Range
0.7000 - 0.7000 - 52 Week Range
0.1200 - 1.0200 - Volume
8,000 - Avg. Volume
12,603 - Market Cap (intraday)
5M - Beta (5Y Monthly) 0.00
- PE Ratio (TTM)
-- - EPS (TTM)
-0.7600 - Earnings Date Nov 6, 2024 - Nov 11, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Cyanotech Corporation, an agricultural company, engages in the production of natural products derived from microalgae worldwide. The company offers BioAstin Hawaiian Astaxanthin, a natural antioxidant to enhance skin, and to support eye, joint and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement to support natural energy, immune system, and cardiovascular health, as well as a source of antioxidant carotenoids. It also provides contract extraction and research and development services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health food, cosmetic manufacturers and nutraceuticals, and dietary supplement markets. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.
www.cyanotech.comRecent News: CYAN
View MorePerformance Overview: CYAN
Trailing total returns as of 9/20/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CYAN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CYAN
View MoreValuation Measures
Market Cap
5.00M
Enterprise Value
14.88M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.20
Price/Book (mrq)
0.47
Enterprise Value/Revenue
0.62
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-21.41%
Return on Assets (ttm)
-9.84%
Return on Equity (ttm)
-39.69%
Revenue (ttm)
23.82M
Net Income Avi to Common (ttm)
-5.1M
Diluted EPS (ttm)
-0.7600
Balance Sheet and Cash Flow
Total Cash (mrq)
720k
Total Debt/Equity (mrq)
99.40%
Levered Free Cash Flow (ttm)
2.66M